文献速递类风湿关节炎其他结缔组织病

吸烟者多中心前瞻性队列中类风湿关节炎间质性肺异常患病率及死亡关联

Prevalence and mortality associations of interstitial lung abnormalities in rheumatoid arthritis within a multicentre prospective cohort of smokers.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

在COPDGene吸烟者多中心前瞻性队列中,83例RA与8725例非RA对照接受研究性胸部高分辨率CT,RA组间质性肺异常(ILA)患病率为16.9%,非RA组为5.0%;校正混杂因素后RA与ILA相关(OR 4.76),合并ILA的RA患者全因死亡风险升高约3倍。

要点

  • 吸烟者中RA组ILA患病率16.9%,非RA对照组5.0%。
  • 校正吸烟、遗传及生活方式因素后,RA与ILA相关(OR 4.76,95%CI 2.54–8.92)。
  • RA合并ILA或ILA不确定者全因死亡风险约为无ILA非RA者的3.16倍。

核心结论

  • 在吸烟者队列中,RA与ILA相关,且校正当前或既往吸烟及遗传、生活方式危险因素后该关联持续存在;合并ILA的RA吸烟者全因死亡风险升高约3倍。

研究设计与样本

  • COPDGene多中心前瞻性队列研究,纳入当前和既往吸烟者,排除已知间质性肺病或支气管扩张者。
  • 所有参与者接受研究性胸部高分辨率CT,按序贯判读法将ILA分为存在、不确定或不存在。
  • RA病例通过自我报告的RA及DMARD使用确定;非RA对照既无RA诊断也未使用DMARD。
  • 共识别83例RA病例和8725例非RA对照,采用多变量logistic回归和Cox回归分析关联及死亡风险。

主要发现

  • ILA患病率在RA病例中为16.9%,在非RA对照中为5.0%。
  • 校正潜在混杂因素(包括遗传、当前或既往吸烟及其他生活方式因素)后,RA较非RA的ILA比值比为4.76(95%CI 2.54–8.92)。
  • RA合并ILA或ILA不确定者较无ILA的非RA者全因死亡风险升高,风险比3.16(95%CI 2.11–4.74)。
  • RA合并ILA或ILA不确定者较无ILA的RA病例全因死亡风险升高,风险比3.02(95%CI 1.36–6.75)。

临床怎么用

  • 作者在结论中指出,合并ILA的RA吸烟者全因死亡风险升高约3倍,强调了对RA临床前间质性肺病进一步筛查和治疗策略的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the prevalence and mortality impact of interstitial lung abnormalities (ILAs) in RA and non-RA comparators. METHODS: We analysed associations between ILAs, RA, and mortality in COPDGene, a multicentre prospective cohort study of current and past smokers, excluding known interstitial lung disease (ILD) or bronchiectasis. All participants had research chest high-resolution CT (HRCT) reviewed by a sequential reading method to classify ILA as present, indeterminate or absent. RA cases were identified by self-report RA and DMARD use; non-RA comparators had neither an RA diagnosis nor used DMARDs. We examined the association and mortality risk of RA and ILA using multivariable logistic regression and Cox regression. RESULTS: We identified 83 RA cases and 8725 non-RA comparators with HRCT performed for research purposes. ILA prevalence was 16.9% in RA cases and 5.0% in non-RA comparators. After adjusting for potential confounders, including genetics, current/past smoking and other lifestyle factors, ILAs were more common among those with RA compared with non-RA [odds ratio 4.76 (95% CI 2.54, 8.92)]. RA with ILAs or indeterminate for ILAs was associated with higher all-cause mortality compared with non-RA without ILAs [hazard ratio (HR) 3.16 (95% CI 2.11, 4.74)] and RA cases without ILA [HR 3.02 (95% CI 1.36, 6.75)]. CONCLUSIONS: In this cohort of smokers, RA was associated with ILAs and this persisted after adjustment for current/past smoking and genetic/lifestyle risk factors. RA with ILAs in smokers had a 3-fold increased all-cause mortality, emphasizing the importance of further screening and treatment strategies for preclinical ILD in RA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. McDermott GC, Hayashi K, Yoshida K, et al. Prevalence and mortality associations of interstitial lung abnormalities in rheumatoid arthritis within a multicentre prospective cohort of smokers. Rheumatology (Oxford). 2023. PMID: 37871923. doi:10.1093/rheumatology/kead277

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。